Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times UK
International Business Times UK
Niloy Chakrabarti

Cathie Wood Offloads Millions of Biotech Shares, Ramps Stake in Veracyte Days Before Earnings Beat

Wood's Ark Invest sold shares of companies mostly dealing with gene sequencing. (Credit: LinkedIn)

ARK Invest CEO Cathie Wood remains steadfast in her reputation for investing in disruptive sectors such as AI, genome development, space exploration, cryptocurrency, and autonomous robotics. Her investment philosophy centres on backing innovations that are shaping the future, often leading her to make bold trades that many institutional investors tend to avoid.

Wood's approach has garnered widespread attention, especially during the COVID-19 pandemic, when her ETFs surged over 100% at their peak in 2020. Her latest filings with the US Securities and Exchange Commission (SEC) reveal significant shifts in her portfolio, particularly within the biotech and healthcare sectors.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.